Evaluation of diazoxide. (Hyperstat I.V.).
D000284:Administration, Oral; D000367:Age Factors; D001794:Blood Pressure; D002302:Cardiac Output / Q000187:drug effects; D002648:Child; D003981:Diazoxide / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D004630:Emergencies; D005069:Evaluation Studies as Topic; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007003:Hypoglycemia / Q000188:drug therapy; D007275:Injections, Intravenous; D011188:Potassium / Q000378:metabolism; D012964:Sodium / Q000378:metabolism; D014665:Vasodilator Agents / Q000627:therapeutic use*
D014665:Vasodilator Agents; D012964:Sodium; D003981:Diazoxide; D011188:Potassium